A preliminary study of JM-27: a serum marker that can specifically identify men with symptomatic benign prostatic hyperplasia.

Cannon GW, Mullins C, Lucia MS, Hayward SW, Lin V, Liu BC, Slawin K, Rubin MA, Getzenberg RH
J Urol. 2007 177 (2): 610-4; discussion 614

PMID: 17222644 · DOI:10.1016/j.juro.2006.09.023

MeSH Terms (7)

Antigens, Neoplasm Biomarkers Humans Male Prostatic Hyperplasia Prostatic Neoplasms Sensitivity and Specificity

Connections (1)

This publication is referenced by other Labnodes entities: